| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.06 | 0.09 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.085 | 0.1 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.36 | 0.1 |
| mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.063 | 0.1 |
| mRNA | BRD-A94377914 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.1 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |